Business · 23/05/2011Updated: 10/17/2026 · 1 min read
FDA Reopens Comment Period for Prescription Drug Tracking System
Summary
The FDA is extending the public comment period for a track-and-trace system for prescription drugs, allowing more time for stakeholders to review and provide feedback on the proposed system attributes.
Original source language: Federal Register — Health and Human ServicesOpen original release →